ScripGilead Sciences' acquisition of Leo Pharma’s signal transducer and activator of transcription 6 (STAT6) program is not just a major boost for the Danish group’s finances but also a nod to the growing
ScripThe pace of new biopharmaceutical financings has slowed as summer enters the last sleepy weeks of August, but the handful of recent significant funding announcements have been quite large, including
ScripSmaller biopharma companies will have a chance to shine at this year’s European Hematology Association congress, with Cargo Therapeutics and Kymera among those already picked out by analysts as ones
ScripKymera Therapeutics, Inc. is in a growth phase on multiple fronts. The company is building out a clinical stage pipeline of oral targeted protein degraders for potentially large immunology indication